Immunocomplex capture fluorescence analysis for donor selection in HLA-haploidentical peripheral blood stem cell transplantation
Transplant Immunology · 2026
DOI: 10.1016/j.trim.2026.102442 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplant Immunology, 2026. Verfasst von Takayo Sakurazawa und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, Japan. Electronic address: takayo-72@huhp.hokudai.ac.jp. Hauptthemen laut MEDLINE: HLA Antigens, Histocompatibility Testing, Peripheral Blood Stem Cell Transplantation, Isoantibodies. Die Arbeit nennt 17 Literaturangaben. Gefördert von: Hokkaido University.
Abstract (Originalsprache)
Donor-specific HLA antibodies (DSA) are associated with graft failure after HLA-mismatched allogeneic hematopoietic stem cell transplantation (HSCT). The most widely used method for identifying anti-HLA antibodies is the single-antigen bead (SAB) assay. Although this method has high sensitivity, it also detects natural HLA antibodies, which are considered to have low clinical significance. Instead, detection of reactivity between recipient serum and donor cells, such as lymphocyte crossmatching, may be useful for HSCT donor selection. We evaluated the efficacy of immunocomplex capture fluorescence analysis (ICFA), a highly sensitive lymphocyte crossmatching technique, as a tool for HSCT donor selection: ICFA was conducted on recipient serum and donor cells prior to HLA-haploidentical peripheral blood stem cell transplantation (haplo-PBSCT) and transplant outcomes were evaluated. Twenty-one patients who had anti-HLA antibodies and underwent haplo-PBSCT between 2019 and 2025 were included. Patients were stratified according to DSA status into Group A (DSA-positive) and Group B (DSA-negative). Six of the seven patients in Group A and all 14 patients in Group B were ICFA-negative. The patient who was ICFA-positive with anti-HLA class I antibodies was the only patient who developed graft failure; all the patients who were ICFA-negative achieved neutrophil engraftment (except one patient in Group B who died before engraftment due to intracerebral hemorrhage), even when they were positive for DSA. Thus, ICFA may be helpful for donor selection for haplo-PBSCT patients with anti-HLA antibodies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, Japan. Electronic address: takayo-72@huhp.hokudai.ac.jp.
- Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, Japan; Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan.
- Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, Japan.
- Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan.
- Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan.
Förderung
- Hokkaido University
Zitieren
APA
Sakurazawa, T., Shiratori, S., Ito, M., Sasaki, M., Masuda, Y., Sugita, J., Matsukawa, T., Ara, T., Hasegawa, Y., Suto, K., Yamashita, N., Goto, H., & Teshima, T. (2026). Immunocomplex capture fluorescence analysis for donor selection in HLA-haploidentical peripheral blood stem cell transplantation. Transplant Immunology. https://doi.org/10.1016/j.trim.2026.102442
Vancouver
Sakurazawa T, Shiratori S, Ito M, Sasaki M, Masuda Y, Sugita J, et al. Immunocomplex capture fluorescence analysis for donor selection in HLA-haploidentical peripheral blood stem cell transplantation. Transplant Immunology. 2026. doi:10.1016/j.trim.2026.102442
BibTeX
@article{Sakurazawa2026,
author = {Sakurazawa, Takayo and Shiratori, Souichi and Ito, Makoto and Sasaki, Maki and Masuda, Yuya and Sugita, Junichi and Matsukawa, Toshihiro and Ara, Takahide and Hasegawa, Yuta and Suto, Keito and Yamashita, Naoki and Goto, Hideki and Teshima, Takanori},
title = {Immunocomplex capture fluorescence analysis for donor selection in HLA-haploidentical peripheral blood stem cell transplantation},
journal = {Transplant Immunology},
year = {2026},
doi = {10.1016/j.trim.2026.102442}
}
EUVIMED